z-logo
open-access-imgOpen Access
Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial
Author(s) -
Keira Markey,
Ryan Ottridge,
James Mitchell,
Caroline Rick,
Rebecca Woolley,
Natalie Ives,
Peter Nightingale,
Alexandra J. Sinclair
Publication year - 2017
Publication title -
jmir research protocols
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.378
H-Index - 9
ISSN - 1929-0748
DOI - 10.2196/resprot.7806
Subject(s) - medicine , randomized controlled trial , drug , pharmacology , clinical trial , safety profile , adverse effect

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom